Cargando…
Pathophysiology and Optimal Treatment of Intracranial Branch Atheromatous Disease
Intracranial branch atheromatous disease (BAD) is a pathological condition characterized by the occlusion of a relatively large perforating branch (700–800 µm) near the orifice of a parent artery due to atherosclerotic plaque-based thrombus (microatheroma). BAD is refractory to treatment and follows...
Autores principales: | Deguchi, Ichiro, Takahashi, Shinichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322737/ https://www.ncbi.nlm.nih.gov/pubmed/37183021 http://dx.doi.org/10.5551/jat.RV22003 |
Ejemplares similares
-
Efficacy of Treatment with and without Initial Clopidogrel Loading in Branch Atheromatous Disease
por: Deguchi, Ichiro, et al.
Publicado: (2023) -
Branch atheromatous disease and treatment
por: Duan, Honglian, et al.
Publicado: (2022) -
Homocysteine and C-Reactive Protein Associated with Progression and Prognosis of Intracranial Branch Atheromatous Disease
por: Men, Xuejiao, et al.
Publicado: (2013) -
Aggressive antiplatelet treatment for acute branch atheromatous disease type infarcts: a 12-year prospective study
por: Yamamoto, Yasumasa, et al.
Publicado: (2014) -
Greater periventricular white matter hyperintensity severity in basilar artery branch atheromatous disease
por: Lin, Po-Chen, et al.
Publicado: (2017)